Negative association between serum adropin and hypertensive disorders complicating pregnancy

Hypertens Pregnancy. 2019 Nov;38(4):237-244. doi: 10.1080/10641955.2019.1657887. Epub 2019 Aug 23.

Abstract

Objective: Study the association of adropin and hypertensive disorders complicating pregnancy (HDCP). Methods: Patients with HDCP were matched with normotensive women (47 pairs). Adropin concentrations were detected by enzyme-linked immunosorbent assay. Results: Compared with the controls, the serum adropin levels were lower in the HDCP group (P < 0.001) and in HDCP subgroups (gestational hypertension, mild preeclampisa, and severe preeclampsia, term, preterm, early onset, and late onset) (all P < 0.05). After adjustment for confounders, adropin remained negatively associated with HDCP (P = 0.027). Conclusion: Lower adropin concentration is significantly associated with HDCP, suggesting that higher or normal adropin levels may be protective against HDCP.

Keywords: Adropin; hypertension; hypertensive disorders complicating pregnancy; pre-eclampsia; pregnancy.

MeSH terms

  • Adult
  • Case-Control Studies
  • Female
  • Humans
  • Hypertension, Pregnancy-Induced / blood*
  • Intercellular Signaling Peptides and Proteins / blood*
  • Pregnancy

Substances

  • Enho protein, human
  • Intercellular Signaling Peptides and Proteins